Related Experiment Video
Updated: Jun 12, 2026
Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Effect of a water-soluble alkylene oxide copolymer based bone hemostat in cardiac surgery: a prospective,
Kentaro Yamane1, Muhammad F Masood2, Shengchun Wang3
1Division of Cardiothoracic Surgery, Penn State College of Medicine, Hershey, PA, USA.
Objectives:
This study evaluated the safety and effectiveness of an Alkylene Oxide Copolymer, Ostene, in controlling bone bleeding in open cardiac surgical patients undergoing median sternotomy.
Design:
Single arm, prospective, post-market study.
Setting:
This study was conducted at 3 centers in the United States.
Participants:
Ninety adult median sternotomy patients in whom Ostene was intended to be bone hemostat.
Interventions:
Ostene used to treat bone bleeding during surgical procedure.
Measurements And Main Results:
Surgical parameters included the area of bone bleeding, severity of bleeding, quantity of Ostene used to stop bone bleeding, time for bone bleeding to stop, time to occurrence of a bone rebleed, and the number of Ostene applications. The use and rationale for using an alternate bone hemostat were also recorded in cases where alternate bone hemostats were used. Adverse events that started from the time of the index procedure until 30 days postoperatively were also recorded.
Main Results:
Intraoperative bone bleeding was successfully controlled with the application of Ostene in 87 of 89 patients (97.8%) who were eligible for effectiveness analyses. Intraoperative rebleeds were observed in 23 of 90 patients (25.6%) 238.1 ± 61.7 min after hemostasis of the original bleed was achieved. Final hemostasis was achieved by reapplying Ostene in 21 patients and alternate bone hemostats in 2 of the 23 patients. None of the patients in the study had postoperative bone bleeding within 24 h of surgery. Few AEs occurred in the study cohort, all unrelated to Ostene.
Conclusions:
Ostene proved to be effective bone hemostat for the control of intraoperative bone bleeding in cardiac surgical patients undergoing median sternotomy.